Fallout from questions raised about the research and journal publications from the lab of Dr. Piero Anversa, a controversial stem cell researcher, leads a federal agency to temporarily halt a clinical trial studying a stem cell therapy for heart failure patients. And The New York Times reports more on Anversa's troubles.
from Kaiser Health News https://ift.tt/2AzYjTz
0 comments:
Post a Comment